- Home
- INDV vs TGS Comparison
INDV vs TGS Comparison
Compare INDV & TGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INDV | TGS |
|---|---|---|
| Founded | N/A | 1992 |
| Country | United States | Argentina |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Natural Gas Distribution |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.6B |
| IPO Year | 2014 | 2002 |
Fundamental Metrics
Financial Performance| Metric | INDV | TGS |
|---|---|---|
| Price | $40.48 | $30.58 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $40.00 |
| AVG Volume (30 Days) | ★ 1.6M | 208.3K |
| Earning Date | 06-08-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 3.01% |
| EPS Growth | ★ 8100.00 | N/A |
| EPS | ★ 0.69 | N/A |
| Revenue | ★ $1,239,000,000.00 | N/A |
| Revenue This Year | N/A | $2.13 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $58.71 | ★ $17.56 |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $16.69 | $19.74 |
| 52 Week High | $42.81 | $36.35 |
Technical Indicators
Market Signals| Indicator | INDV | TGS |
|---|---|---|
| Relative Strength Index (RSI) | 53.87 | 50.10 |
| Support Level | $39.20 | $30.08 |
| Resistance Level | $41.42 | $31.92 |
| Average True Range (ATR) | 1.37 | 1.02 |
| MACD | -0.15 | 0.13 |
| Stochastic Oscillator | 56.03 | 52.68 |
Price Performance
Historical ComparisonAbout INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
About TGS Transportadora de Gas del Sur SA TGS
Transportadora de Gas del Sur SA is a natural gas transporter in Latin America. The company's operating segments include Natural Gas Transportation, Midstream, Telecommunications, and Liquids Production and Commercialization. It generates maximum revenue from the Natural Gas Transportation segment. Geographically, it derives the majority of its revenue from Argentina.